News
Events
Shiner signs the agreement with Australian biopharmaceutical company for marketing a new HIV treatment.
Certificate / License
Shiner's Pantopro Gastro-Resistant Tablets 40mg receives TFDA approval; combining two appropriate antimicrobial agents.
Certificate / License
Shiner's Reosteo 35mg Tablets receives TFDA approval. (ANDA, API: risedronate sodium)
Events
Exclusive Supply and Distribution Contract Signed with an Italian Company for Chemotherapy-Induced Oral Mucositis Products.
Events
Shiner signs the agreement with a Canadian company for endocrine products and exclusive supply and distribution.
Certificate / License
The collection of Hanlosin S.R.O.D. Tablets 0.2 mg. (ANDA, API: Tamsulosin hydrochloride)
Events